Cleveland BioLabs Submits Proposal to BARDA for Development Funding for Entolimod(TM) (CBLB502)
[at noodls] – Download PDF BUFFALO, N.Y., Oct. 18, 2012 (GLOBE NEWSWIRE) — Cleveland BioLabs, Inc. (Nasdaq:CBLI) today announced it has submitted a proposal to the Biomedical Advanced Research and Development Authority … more
View todays social media effects on CBLI
View the latest stocks trending across Twitter. Click to view dashboard